Found 7 results in Media Advisories
Catalent Clarifies Novo Nordisk Ownership of Former Bloomington, Indiana Site
October 17, 2025
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
October 8, 2025
Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research
September 2, 2025
MEDIA ALERT :Catalent Boston Announces Technology Upgrade to meet the needs of Global Customers
July 28, 2025
Gov. Evers, WEDC celebrate Catalent’s $45 Million expansion, adding to the state’s booming biohealth sector
July 2, 2025
Silexion Therapeutics Announces Collaboration with Global Therapeutics Leader Catalent on Advanced siRNA Formulation Development & Clinical Manufacturing Activities
April 23, 2025
Lisata Therapeutics Announces Research License with Catalent
April 15, 2025